Biotech

All Articles

Galapagos' stockpile as fund reveals intent to shape its own advancement

.Galapagos is actually coming under extra pressure coming from financiers. Having built a 9.9% conce...

Cell- centered Sana scoops very first CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of considerable management hirings, shootings an...

Allist pays off Jacobio $21M, landing job in Mandarin KRAS ethnicity

.Shanghai Allist Pharmaceuticals has purchased on its own a starring role in China's KRAS market, sp...

ReNeuron leaving AIM substitution after missing fundraising objective

.ReNeuron has participated in the lengthy list of biotechs to leave London's goal securities market....

MBX files for IPO to take opposition to Ascendis right into period 3

.MBX Biosciences has contributed to the recent flurry of IPO filings. The biotech, which filed its o...

FDA increases probing right into Lykos' MDMA tests: WSJ

.For Lykos Rehabs and the company's prospective MDMA-assisted treatment for trauma (POST-TRAUMATIC S...

Gene editor Volume giving up 131 laborers

.Merely days after genetics editor Volume Biosciences declared hidden functional cuts, a more clear ...

Repare gives up 25% of staff as biotech halts preclinical R&ampD

.Repare Rehab is laying off an one-fourth of its labor force as the oncology biotech scales back its...

J &amp J files for FDA permission of $6.5 B autoimmune medication

.Johnson &amp Johnson has gotten an additional measure towards realizing a return on its $6.5 billio...

Gain's phase 1 win leads means to show Parkinson's drug's worth

.Increase Rehabs has established its own sights on confirming the performance of its own Parkinson's...